Delphine Garnier

9PUBLICATIONS
20CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 07, 2026
Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction.

Marianne Ayoub, Casilda Hitier, Léa Dehgane

|Dec 09, 2025
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.

Léa Dehgane, Eliane Mallet, Constance Brasseur

|Dec 06, 2023
ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia.

Mariana Tannoury, Marianne Ayoub, Léa Dehgane

|Sep 26, 2023
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia.

Ludovic Jondreville, Lea Dehgane, Cecile Doualle

|May 16, 2023
Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?

Kenza Dubois, Mariana Tannoury, Brigitte Bauvois

|Dec 23, 2022
Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next?

Mariana Tannoury, Delphine Garnier, Santos A Susin

Pageof 2

Frequent Collaborators

5 joint publications

Santos A Susin

4 joint publications

Elise Chapiro

3 joint publications

Karim Maloum

3 joint publications

Kenza Dubois